Stop Spot
FDA Label NDC 72521-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Clearly Pte Ltd for the product Stop Spot (NDC 72521-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, active ingredient, purpose, uses, warnings, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Drug Facts

Active Ingredient

Salicylic Acid 2%

Purpose

Acne treatment

Uses

Clears acne blemishes and allows the skin to heal

Warnings

For External Use Only

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time

Keep out of Reach of Children, if ingested, seek medical help or contact Poison
Control Center immediately

Directions

  • Clean the skin thoroughly before applying this product
  • cover the entire affected area/spot with a thin layer one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
    • if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other Information

Store below 30°C (86° F)

Inactive Ingredients

water, alcohol denat, glycerin, butylene glycol, propanediol, PEG-30 castor oil, dipotassium glycyrrhizate, phenoxyethanol, glycolic acid, sclerotium gum,xanthum gum, sodium hydroxide, farnesol, ethylhexylglycerin, sulfur

Product Label

Image Description (Image2 V1)

Image Description (Image2 V1)

Image Description (Image1 V2)

Image Description (Image1 V2)

* Please review the disclaimer below.